CHAPTER 10 – Interleukin-4

作者: H OKADA , J BANCHEREAU , M LOTZE

DOI: 10.1016/B978-012689663-3/50014-4

关键词: CytokineImmune systemEffectorInterleukinBiologyAntigen presentationInterleukin 4Signal transductionGene deliveryImmunology

摘要: This chapter focuses on interleukin (IL)-4, which is produced by and affects many cell types. The biological milieu provides signals for the production of IL-4, at same time, effects IL-4 depend timing maturation/activation stage influences differentiation effector cells level antigen presentation, activation T cells. presence other cytokines can also dramatically change outcome an immune response. For cancer patients, local delivery gene vectors may hold more promise than recombinant achieving high concentration cytokine site induction anti-tumor Development effective regulatable systems allow to design combination strategies multiple based a deeper understanding how each plays role in sequence events. Understanding receptors their expression has led development toxin-conjugated treatment cancer. Soluble forms receptor be important patients with allergic diseases. In diseases excess HI shifted balance apparent, such as chronic inflammatory diseases, rIL-4 or therapeutic benefit. signal transduction, messenger molecules well structure IL-4R, complexes specific inhibitors enhancers complex biologic properties IL-4.

参考文章(368)
Hiromichi Mitsuyasu, Kenji Izuhara, Xiao-Quan Mao, Pei-Song Gao, Yojiro Arinobu, Tadao Enomoto, Mitsuru Kawai, Sei Sasaki, Yasuhiro Dake, Naotaka Hamasaki, Taro Shirakawa, Julian M. Hopkin, Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nature Genetics. ,vol. 19, pp. 119- 120 ,(1998) , 10.1038/472
C. Schindler, H. Kashleva, A. Pernis, R. Pine, P. Rothman, STF-IL-4: a novel IL-4-induced signal transducing factor. The EMBO Journal. ,vol. 13, pp. 1350- 1356 ,(1994) , 10.1002/J.1460-2075.1994.TB06388.X
Hano Toru, Tatsuo Kinashi, Chisei Ra, Shigeaki Nonoyama, Jun-ichi Yata, Tatsutoshi Nakahata, Interleukin-4 induces homotypic aggregation of human mast cells by promoting LFA-1/ICAM-1 adhesion molecules. Blood. ,vol. 89, pp. 3296- 3302 ,(1997) , 10.1182/BLOOD.V89.9.3296
J. G. Shields, R. E. Callard, B. N. Jamieson, R. J. Armitage, P. C. L. Beverley, Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4. Immunology. ,vol. 66, pp. 224- 227 ,(1989)
Steve N. Georas, John E. Cumberland, Thomas F. Burke, Rongbing Chen, Ulrike Schindler, Vincenzo Casolaro, Stat6 inhibits human interleukin-4 promoter activity in T cells Blood. ,vol. 92, pp. 4529- 4538 ,(1998) , 10.1182/BLOOD.V92.12.4529
A Manabe, E Coustan-Smith, M Kumagai, FG Behm, SC Raimondi, CH Pui, D Campana, Interleukin-4 Induces Programmed Cell Death (Apoptosis) in Cases of High-Risk Acute Lymphoblastic Leukemia Blood. ,vol. 83, pp. 1731- 1737 ,(1994) , 10.1182/BLOOD.V83.7.1731.1731
C Favre, S Saeland, C Caux, V Duvert, JE De Vries, Interleukin-4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells Blood. ,vol. 75, pp. 67- 73 ,(1990) , 10.1182/BLOOD.V75.1.67.67
L Flores-Romo, S Gillis, J Gordon, M J Millsum, Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40. Immunology. ,vol. 68, pp. 526- 531 ,(1989)